Whereas the triggering mechanisms of inflammation in T2DM pathogenesis are still ill-understood, the implications of chronic activation of proinflammatory pathways in target cells of insulin action likely contribute to various metabolic disorders, including T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.